Preclinical evaluation of bafetinib for treatment of glioblastoma multiforme.

被引：0
|
作者：
Veicheti, V.
Peterson, B.
Levitt, D.
Prakash, O.
机构：
[1] Ochsner Clin Fdn, New Orleans, LA USA
[2] CytRx Corp, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2082
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Economic evaluation of temozolomide in the treatment of recurrent glioblastoma multiforme
    Janne A. Martikainen
    Akseli Kivioja
    Taru Hallinen
    Pia Vihinen
    PharmacoEconomics, 2005, 23 : 803 - 815
  • [42] Economic evaluation of temozolomide in the treatment of recurrent glioblastoma multiforme
    Martikainen, JA
    Kivioja, A
    Hallinen, T
    Vihinen, P
    PHARMACOECONOMICS, 2005, 23 (08) : 803 - 815
  • [43] Determining viability of using APNG status as a prognostic marker in patients with glioblastoma multiforme.
    Dahlrot, Rikke Hedegaard
    Hellwege, Sofie
    Fosmark, Sigurd
    Jensen, Kristian Lindstroem
    Lohse, Jesper
    Derand, Helene
    Hjelmborg, Jacob
    Hansen, Steinbjorn
    Kristensen, Bjarne Winther
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [44] Age and molecular subgrouping determine the predictive value of prognostic markers in glioblastoma multiforme.
    Simmons, ML
    Barker, F
    Burwick, J
    Lamborn, K
    Berger, M
    Miller, T
    Chen, P
    Prados, M
    Aldape, K
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1999, 58 (05): : 513 - 513
  • [45] Combined inhibition of MEK and PI3 kinase signaling results in improved survival in a preclinical orthotopic model for human glioblastoma multiforme.
    El Meskini, Rajaa
    Iacovelli, Anthony
    Kulaga, Alan
    Gumprecht, Michelle
    Martin, Philip L.
    Baran, Maureen L.
    Householder, Deborah B.
    Van Dyke, Terry
    Ohler, Zoe Weaver
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [46] Radiochirurgie des Glioblastoma multiforme in der RezidivsituationHeidelberger Erfahrungen im LiteraturvergleichThe value of radiosurgery for recurrent glioblastoma multiforme. The Heidelberg experience and review of the literature
    M. van Kampen
    R. Engenhart-Cabillic
    J. Debus
    M. Fuß
    B. Rhein
    M. Wannenmacher
    Strahlentherapie und Onkologie, 1998, 174 (1) : 19 - 24
  • [47] Using a prospective comprehensive database to define features that impact the outcome of patients with glioblastoma multiforme.
    Field, K. M.
    Rosenthal, M.
    Kosmider, S.
    Gibbs, P.
    Drummond, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [48] Dual chlorotoxin and methylguanine methyltransferase γδ-T cells for drug resistant immunotherapy of glioblastoma multiforme.
    Ding, Lei
    Lamb, Lawrence S.
    CANCER RESEARCH, 2021, 81 (13)
  • [49] Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme
    Bryant, Nichole L.
    Gillespie, G. Yancey
    Lopez, Richard D.
    Markert, James M.
    Cloud, Gretchen A.
    Langford, Catherine P.
    Arnouk, Hilal
    Su, Yun
    Haines, Hilary L.
    Suarez-Cuervo, Catalina
    Lamb, Lawrence S., Jr.
    JOURNAL OF NEURO-ONCOLOGY, 2011, 101 (02) : 179 - 188
  • [50] Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme
    Nichole L. Bryant
    G. Yancey Gillespie
    Richard D. Lopez
    James M. Markert
    Gretchen A. Cloud
    Catherine P. Langford
    Hilal Arnouk
    Yun Su
    Hilary L. Haines
    Catalina Suarez-Cuervo
    Lawrence S. Lamb
    Journal of Neuro-Oncology, 2011, 101 : 179 - 188
12345